Gregory S. Curhan
Chief Financial Officer · Serina Therapeutics, Inc.
Individual
- 2026
- May 26, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gregory S. Curhan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Randall Moreadith - $377K in SER purchases and sales in the last 12 months
- Karen J. Wilson - $55K in SER purchases and sales in the last 12 months
- Richard Peter Marshall - $20K in SER purchases and sales in the last 12 months
- Stephen K. Brannan - $2K in SER purchases and sales in the last 12 months
- Jay Venkatesan - $1K in SER purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gregory S. Curhan?
Gregory S. Curhan is a corporate insider, tracked as Chief Financial Officer of Serina Therapeutics, Inc. (SER). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Gregory S. Curhan last file a Form 4?
The only primary Form 4 on record is dated 26 May 2026.